Omada Health holder plans $86.8K stock sale

Wei-Li Shao filed a Rule 144 notice to sell 4,036 OMDA common shares, following earlier 10b5-1 sales in June and August 2026.

Available on EDGAR 09/10/2026 - 05:18 PM EDT Accepted by SEC EDGAR 09/10/2026 - 05:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) received a notice that stockholder Wei-Li Shao intends to sell up to 4,036 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares were acquired upon vesting of restricted stock units during the period from September 1, 2026 through September 5, 2026.

The notice also lists prior Rule 10b5-1 sales of Omada Health common stock for this holder over the preceding three months, including 9,418 shares sold on August 12, 2026 and 4,037 shares sold on June 12, 2026.

Key Figures

Shares covered by Rule 144 notice: 4,036 shares Aggregate market value of planned sale: $86,774.00 10b5-1 sale on August 12, 2026: 9,418 shares; $235,615.76 +2 more

5 metrics

Shares covered by Rule 144 notice 4,036 shares Common stock of Omada Health to be sold by Wei-Li Shao

Aggregate market value of planned sale $86,774.00 Value associated with 4,036 shares of common stock in Rule 144 notice

10b5-1 sale on August 12, 2026 9,418 shares; $235,615.76 Prior sale of Omada Health common stock in last three months

10b5-1 sale on June 12, 2026 4,037 shares; $69,600.71 Prior sale of Omada Health common stock in last three months

Period of RSU vesting September 1, 2026 through September 5, 2026 Period when RSUs vested that generated the 4,036 shares

Key Terms

Rule 144, Restricted Stock Units, 10b5-1 Sales, Common

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | | | 4036 | 09/01/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for WEI-LI SHAO 611 Gateway Blvd"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Common financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Omada Health (OMDA)?

It discloses that Wei-Li Shao has filed a Rule 144 notice to potentially sell 4,036 shares of Omada Health common stock, acquired from vested restricted stock units between September 1 and September 5, 2026, through Morgan Stanley Smith Barney LLC.

How many Omada Health (OMDA) shares are proposed to be sold under this Form 144?

The notice covers up to 4,036 shares of Omada Health common stock to be sold. The securities were acquired upon vesting of restricted stock units during the period from September 1, 2026 through September 5, 2026.

What is the aggregate market value of the Omada Health (OMDA) shares in this planned Rule 144 sale?

The filing lists an aggregate market value of $86,774.00 for the 4,036 shares of Omada Health common stock that are covered by this Rule 144 notice.

What Omada Health (OMDA) shares has Wei-Li Shao sold in the past three months?

The filing lists 9,418 shares of Omada Health common stock sold on August 12, 2026 for $235,615.76 and 4,037 shares sold on June 12, 2026 for $69,600.71, both identified as 10b5-1 sales.

How were the Omada Health (OMDA) shares in this Form 144 obtained?

According to the notice, the 4,036 shares to be sold were acquired upon the vesting of restricted stock units during the period from September 1, 2026 through September 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002069137
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Omada Health, Inc.
SEC File Number	001-42679
Address of Issuer	611 Gateway Blvd, Suite 120 South San Francisco CALIFORNIA 94080
Phone	8889878337
Name of Person for Whose Account the Securities are To Be Sold	WEI-LI SHAO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4036	86774.00	61216703	09/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Units	Issuer			4036	09/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WEI-LI SHAO 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	08/12/2026	9418	235615.76
10b5-1 Sales for WEI-LI SHAO 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/12/2026	4037	69600.71

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 9/1/2026 through 9/5/2026.
Date of Notice	09/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wei-Li Shao
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)